Financière de Tubize SA (EBR:TUB)

Belgium flag Belgium · Delayed Price · Currency is EUR
195.70
-6.50 (-3.21%)
Apr 28, 2026, 5:39 PM CET
65.29%
Market Cap 9.00B
Revenue (ttm) n/a
Net Income (ttm) 93.23M
Shares Out 44.51M
EPS (ttm) 2.09
PE Ratio 96.54
Forward PE n/a
Dividend 1.08 (0.53%)
Ex-Dividend Date Apr 30, 2025
Volume 39,245
Average Volume 25,520
Open 200.80
Previous Close 202.20
Day's Range 192.80 - 201.00
52-Week Range 114.80 - 250.50
Beta 0.42
RSI 36.79
Earnings Date Mar 21, 2026

About Financière de Tubize

Financière de Tubize SA operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium. It engages in discovering and developing treatments for patients suffering from serious illnesses that affect the immune system or the central nervous system. The company was incorporated in 1928 and is based in Brussels, Belgium. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1928
Employees 3
Stock Exchange Euronext Brussels
Ticker Symbol TUB
Full Company Profile

Financial Performance

Financial Statements

News

Financière de Tubize Earnings Call Transcript: H2 2025

Maintains a 36% stake in UCB, focusing on long-term value and readiness to support UCB's growth, with strong stock price and TSR performance driven by UCB's key products. Dividend growth slowed to 4% as reserves are prioritized for strategic flexibility.

5 weeks ago - Transcripts